Integrated Biology Platform
Delivering comprehensive solutions from early discovery through IND-enabling translational studies
In-vivo services
PRECEDO’s in vivo biology platform delivers translationally relevant pharmacology models to evaluate efficacy, mechanism of action, and disease relevance across oncology, immune-mediated, and metabolic disorders.
Why Choose PRECEDO In Vivo Services?
- Translational Models – Efficacy, MoA, and disease relevance across multiple therapeutic areas
- Integrated Portfolio – Genetically defined models, PDX, and immune competent systems
- Comprehensive Assessment – Target dependency, resistance mechanisms, therapeutic response
- Flexible Study Design – Supports preclinical validation and IND enabling studies
- Clinically Meaningful Outcomes – Bridges in vitro findings to real world clinical relevance